Literature DB >> 12711818

A two-year analysis of risk factors and outcome in patients with bloodstream infection.

Andrea Endimiani1, Antonio Tamborini, Francesco Luzzaro, Gianluigi Lombardi, Antonio Toniolo.   

Abstract

A two-year analysis was performed at our hospital to evaluate the incidence and clinical impact of bloodstream infections (BSI) in medical, surgical, and intensive care unit patients. During 1999-2000 there were 521 cases of BSI with an incidence of 10.1/1,000 admissions. The most frequent predisposing factors for BSI were intravascular catheter (56.4%) and previous use of antibiotics (50.9%). Infections were considered as primary in 67.9% of cases. Urinary tract and intravascular catheter were the most frequent source of secondary bacteremia (43.1% and 35.9%, respectively). At the time of the first positive blood culture, 83.5% of patients were receiving empirical treatment, but it was adequate in only 53.9% of cases. After antimicrobial susceptibility testing, adequate antibiotic treatment was given in 67.9% of cases. Statistical analysis of independent risk factors showed that mortality was significantly related to age (P < 0.048), rapidly-fatal diseases (P < 0.001), septic shock (P < 0.020), multiorgan failure (P < 0.001), previous use of antibiotics (P < 0.008), Enterobacteriaceae producing extended-spectrum beta-lactamases (P < 0.036), and inadequate empirical treatment (P < 0.039). Based on local epidemiology and susceptibility data, microbiology laboratories should periodically release recommendations on the optimal empirical treatment for different wards.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12711818

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  9 in total

1.  Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia.

Authors:  Regina B Osih; Jessina C McGregor; Shayna E Rich; Anita C Moore; Jon P Furuno; Eli N Perencevich; Anthony D Harris
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

2.  Secular trends in the appropriateness of empirical antibiotic treatment in patients with bacteremia: a comparison between three prospective cohorts.

Authors:  Vered Daitch; Yulia Akayzen; Yasmin Abu-Ghanem; Noa Eliakim-Raz; Mical Paul; Leonard Leibovici; Dafna Yahav
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-20       Impact factor: 3.267

3.  Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases.

Authors:  Andrea Endimiani; Francesco Luzzaro; Gioconda Brigante; Mariagrazia Perilli; Gianluigi Lombardi; Gianfranco Amicosante; Gian Maria Rossolini; Antonio Toniolo
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

4.  Effects of Inappropriate Administration of Empirical Antibiotics on Mortality in Adults With Bacteraemia: Systematic Review and Meta-Analysis.

Authors:  Yuan-Pin Hung; Ching-Chi Lee; Wen-Chien Ko
Journal:  Front Med (Lausanne)       Date:  2022-05-30

5.  ESBL production and carbapenem resistance increased the secondary bloodstream infection rates in intensive care units in Turkey, 2014-2019.

Authors:  Can Huseyin Hekimoglu; Serap Suzuk Yildiz; Selda Sahan; Esen Batir; Emine Yildirim Gozel; Dilek Altun; Gulen Pehlivanturk; Muhammet Comce; Fatih Kara
Journal:  GMS Hyg Infect Control       Date:  2022-04-11

6.  Effects of type and level of training on variation in physician knowledge in the use and acquisition of blood cultures: a cross sectional survey.

Authors:  Jorge P Parada; David N Schwartz; Gordon D Schiff; Kevin B Weiss
Journal:  BMC Infect Dis       Date:  2005-09-15       Impact factor: 3.090

7.  Bacteraemia predictive factors among general medical inpatients: a retrospective cross-sectional survey in a Japanese university hospital.

Authors:  Sayato Fukui; Yuki Uehara; Kazutoshi Fujibayashi; Osamu Takahashi; Teruhiko Hisaoka; Toshio Naito
Journal:  BMJ Open       Date:  2016-07-07       Impact factor: 2.692

8.  Impact of appropriate empirical antibiotic treatment on recurrence and mortality in patients with bacteraemia: a population-based cohort study.

Authors:  Kim O Gradel; Ulrich S Jensen; Henrik C Schønheyder; Christian Østergaard; Jenny D Knudsen; Sonja Wehberg; Mette Søgaard
Journal:  BMC Infect Dis       Date:  2017-02-06       Impact factor: 3.090

9.  Risk factors for nosocomial bloodstream infections in COVID-19 affected patients: protocol for a case-control study.

Authors:  Carla Codina-Jiménez; Sergio Marin; Marlene Álvarez; Maria Dolores Quesada; Beatriz Rodríguez-Ponga; Ester Valls; Carles Quiñones
Journal:  Eur J Hosp Pharm       Date:  2021-08-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.